Legal Representation
Attorney
Maury M. Tepper, III
USPTO Deadlines
Next Deadline
1466 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-07-18)
Due Date
July 18, 2029
Grace Period Ends
January 18, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
45 events| Date | Code | Type | Description |
|---|---|---|---|
| Nov 6, 2023 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Oct 18, 2023 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Oct 18, 2023 | FIMP | P | FINAL DISPOSITION PROCESSED |
| Oct 18, 2023 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| Jul 18, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Jul 18, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| May 2, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 2, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| May 1, 2023 | GPNX | P | NOTIFICATION PROCESSED BY IB |
| Apr 19, 2023 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Apr 12, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Apr 12, 2023 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Apr 12, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Mar 30, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Mar 30, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Mar 30, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Mar 30, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Mar 30, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Mar 30, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 29, 2023 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Mar 29, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Mar 28, 2023 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Mar 28, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 12, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Oct 27, 2022 | CNFR | R | FINAL REFUSAL WRITTEN |
| Oct 27, 2022 | GNFR | O | FINAL REFUSAL E-MAILED |
| Oct 27, 2022 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Sep 8, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sep 8, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sep 8, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sep 8, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Sep 8, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Sep 8, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Sep 8, 2022 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Sep 8, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Sep 8, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Aug 2, 2022 | RFNT | P | REFUSAL PROCESSED BY IB |
| Jul 11, 2022 | RFRR | P | REFUSAL PROCESSED BY MPU |
| Jul 11, 2022 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Jun 22, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Jun 21, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jun 11, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Nov 6, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Nov 2, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Oct 28, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 005
In vitro diagnostic agents for medical use
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Analyzers for medical purposes, namely, polymerase chain reaction (PCR) instruments for the analysis of body fluids for use in detecting and diagnosing infectious disease; analyzers for medical purposes, namely, analyzers for performing amplification and analysis of nucleic acid assays, enzyme-linked immunosorbent assays (ELISA), immunochromatographic assays (ICT), and western blot assays and protein immunoblot assays; all of the foregoing for medical analysis purposes
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
010
USPTO Documents
Loading USPTO documents...